Education, Disclosures, and Bias, Oh My! (Part Two of Two) January 24, 2011
Posted by Joshua M. Cooper, MD, FACC in Education, Industry.Tags: Conflict of Interest, Financial disclosures, Industry, Medical education
1 comment so far
Part 2: Evaluating the Paradigm of Industry Sponsorship of Medical Education
In my previous entry, “Part 1: The Case for In-Person, National Meetings,” I made the argument that medical education programs remain necessary to maximize the quality of health care delivery, and that in-person learning opportunities are likely more effective than computer-based self-study modules or webcasts. In fact, in this era of rapidly-growing medical knowledge and rapidly-shrinking training time for residents and fellows, one could argue that medical education programs are more vital than ever before. (more…)
Sunshine Act and COIs: Too Much Transparency? May 15, 2010
Posted by Ariana Del Negro, Heart Rhythm 2010 Quality in Scientific Sessions.Tags: Conflict of Interest, Financial disclosures, Healthcare reform
add a comment
In the interest of moving towards greater transparency across the health care system, the new health care reform legislation includes the Physician Payment Sunshine Act, which will make it mandatory, by 2013, for all drug and medical device manufacturers to publicly report gifts and payments of value greater than $10 made to physicians and teaching hospitals in any one year. Disclosures to the federal government will include physician name, address, national provider identifier (NPI, related to Medicare and other payment programs), the value and form of the payment, as well as the specific drug or device the payment was related to. Beginning September 30, 2013 and each year thereafter, the information will be entered into a searchable database made available online. Of potential concern is the fact that this information (with the exception of the NPI) will be made available to the general public. And the general public is not only your patients, friends, neighbors, etc., but also the institutions that you work for, and, of course, lawyers. In essence and aptly put by Eric G. Campbell, PhD (Mongan Institute for Health Policy, Massachusetts General Hospital) during the Health Policy Town Hall Session at this year’s Heart Rhythm 2010, the release of this information means that “everyone is going to know your business.”
Conflict of Interest in Medicine, Professional Education and Research: The times they are a changing February 9, 2010
Posted by Bruce Stambler, MD in Education, Industry.Tags: CME, Conflict of Interest, Financial disclosures
add a comment
“What was O.K. three years ago is not O.K. now.”
This recent quote by Dr. Eugene Braunwald in the New York Times highlights the fact that the landscape regarding conflicts of interest for physicians is changing rapidly and will likely continue to evolve in new and perhaps unanticipated ways. Undoubtedly, we can survive without pens and other unnecessary plastic objects emblazoned with company logos, however the changes that we are witnessing raise many questions.
Will the practice of medicine, professional education and clinical and basic research suffer adverse, long-lasting consequences from externally or internally imposed restrictions that limit physician and professional society relationships with the device and pharmaceutical industries? Will it be that the die already is cast and we will be overtaken by events and policies imposed by others outside our profession or will actions taken by us now forestall or meaningfully shape these changes? Will our professional associations take a leadership role and educate the public and our governmental officials on the benefits to society of the longstanding relationships between industry and physicians? Or will we leave it to the media or media-seeking public officials to criticize these relationships with hyperbole and embellishment, providing fodder for those who simply believe that physicians are motivated only by dollar signs? Will some of the more drastic changes and recommendations that have been proposed be imposed on us, whether we like it or not, or will we be able to adapt to a new environment so as to maintain the levels of excellence in American medicine that we and the public have come to expect? (more…)